Aziz Kabeer — SEC insider filings

SEC reporting owner CIK 1914847. 23 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2022-03-31 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AN2 Therapeutics, Inc. (ANTX)Director231 leg · 166,666 sh · $2,499,99020 legs · 223,880 sh · $3,976,72927

Insider filings — Aziz Kabeer

FiledFormIssuerReported transactionsSource
2026-10-134AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 2,465 @ $0EDGAR
2026-07-104AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 2,852 @ $0EDGAR
2026-04-104AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 3,775 @ $0EDGAR
2026-03-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 20,724 (derivative) · Disposition to issuer (D): 20,724 (derivative) · Grant/award (A): 23,742 (derivative) · Disposition to issuer (D): 23,742 (derivative)EDGAR
2026-02-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 20,400 (derivative) @ $0EDGAR
2026-01-144AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 11,560 @ $0EDGAR
2025-10-144AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 10,367 @ $0EDGAR
2025-07-114AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 11,875 @ $0EDGAR
2025-05-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 19,111 (derivative) @ $0EDGAR
2025-04-114AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 9,705 @ $0EDGAR
2024-12-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 8,972 @ $0EDGAR
2024-06-214AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 64,503 (derivative) @ $0EDGAR
2024-01-184AN2 Therapeutics, Inc. (ANTX)Sale (S): 84,093 @ $19.65 · Sale (S): 15,907 @ $19.65EDGAR
2023-11-164AN2 Therapeutics, Inc. (ANTX)Sale (S): 1,522 @ $16.15 · Sale (S): 288 @ $16.15EDGAR
2023-10-034AN2 Therapeutics, Inc. (ANTX)Sale (S): 83,337 @ $16.28 · Sale (S): 15,764 @ $16.28 · Sale (S): 4,770 @ $16.07 · Sale (S): 902 @ $16.07EDGAR
2023-09-294AN2 Therapeutics, Inc. (ANTX)Sale (S): 707 @ $16.07 · Sale (S): 134 @ $16.07 · Sale (S): 7,160 @ $16.11 · Sale (S): 1,356 @ $16.11EDGAR
2023-09-154AN2 Therapeutics, Inc. (ANTX)Sale (S): 336 @ $16 · Sale (S): 64 @ $16EDGAR
2023-09-084AN2 Therapeutics, Inc. (ANTX)Sale (S): 3,164 @ $16.02 · Sale (S): 598 @ $16.02 · Sale (S): 2,841 @ $16.05 · Sale (S): 537 @ $16.05EDGAR
2023-08-254AN2 Therapeutics, Inc. (ANTX)Sale (S): 336 @ $16 · Sale (S): 64 @ $16EDGAR
2023-06-094AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 23,742 (derivative) @ $0EDGAR
2022-06-244AN2 Therapeutics, Inc. (ANTX)Other (J): 26,511 @ $15 · Other (J): 26,511 @ $15EDGAR
2022-05-164AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 20,724 (derivative) @ $0EDGAR
2022-03-314AN2 Therapeutics, Inc. (ANTX)Conversion (C): 1,651,636 · Conversion (C): 312,415 · Conversion (C): 392,433 · Conversion (C): 74,230 · Purchase (P): 166,666 @ $15 · Conversion (C): 1,651,636 (derivative) @ $0 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2022-03-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1914847 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs